Old Web
English
Sign In
Acemap
>
authorDetail
>
Hiroki Goto
Hiroki Goto
Daiichi Sankyo
Cancer research
Diffuse large B-cell lymphoma
Medicine
antitumor activity
dual inhibitor
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
EZH1/2 Dual Inhibitor Valemetostat Tosylate (DS-3201b) Acts Differently from EZH2 Selective Inhibitor on Epigenetic Landscape to Exert Greater Anti-Tumor Effect Against Diffuse Large B-Cell Lymphoma
2021
Blood
Toshihiro Banjo
Yasuhiro Hama
Emi Nosaka
Yoshimi Takata
Daisuke Honma
Mayumi Kitagawa
Yuka Yamamoto
Chisa Wada
Takanori Yoshida
Kyungtaek Lim
Atsushi Okamoto
Erina Sato
Yumiko Katayama
Kazumi Sato
Hiroki Goto
Yuki Abe
Show All
Source
Cite
Save
Citations (0)
MO4-1 EGFR inhibitor upregulates HER3 expression and enhances the efficacy of anti-HER3 antibody drug conjugate U3-1402
2021
Annals of Oncology
Kimio Yonesaka
Junko Tanizaki
Osamu Maenishi
Hisato Kawakami
Kaoru Tanaka
Hidetoshi Hayashi
Masayuki Takeda
Kazuko Sakai
Maki Kobayashi
Ryoto Yoshimoto
Hiroki Goto
Masanori Funabashi
Yuuri Hashimoto
Kenji Hirotani
Takashi Kagari
Kazuto Nishio
Kazuhiko Nakagawa
Show All
Source
Cite
Save
Citations (0)
Anti-Tumor Effect of the EZH1/2 Dual Inhibitor Valemetostat Against Diffuse Large B-Cell Lymphoma Via Modulation of B-Cell Receptor Signaling and c-Myc Signaling Pathways
2019
Blood
Yasuhiro Hama
Toshihiro Banjo
Daisuke Honma
Yoshimi Takata
Emi Nosaka
Machiko Shiroishi
Kenji Watanabe
Yuka Yamamoto
Tsuyoshi Hirata
Rika Nakano
Koichiro Inaki
Hiroki Goto
Yusuke Totoki
Miki Kataoka
Kyungtaek Lim
Chisa Wada
Eiji Kumazawa
Shinji Tsutsumi
Show All
Source
Cite
Save
Citations (1)
1